>ABOUT TAKEDA>Expressing Takeda in Numbers

Market Presence in over 70 Countries and Regions

The network of the Takeda group spans over 70 countries and regions worldwide, in Japan, the United States, Europe, Latin America, Africa, the Middle East, and the Asia Pacific Region. Takeda's pharmaceutical products are marketed in around 100 countries worldwide, including partnerships (marketing alliance partners).

Takeda's net sales by region (Fiscal 2013)

  • Japan :
    733.9 billion yen
  • North Americas :
    374.5 billion yen
  • Latin America :
    81.2 billion yen
  • Europe :
    297.5 billion yen
  • Russia/CIS :
    89.6 billion yen
  • Asia :
    85.4 billion yen
  • Others :
    29.5 billion yen

(As of March 31, 2014)

  • 0

  • 0

  • 0

  • .

  • 0

  • 0

  • 0

  • 0

  • .

  • 0

  • 0

  • 0

  • 0

  • ,

  • 0

  • 0

  • 0

  • .

  • 0

  • 0

  • 0

  • ,

  • 0

  • 0

  • 0

  • ,

  • 0

  • 0

  • 0

  • ,

  • 0

18 R&D Sites

A global pharmaceutical company with 18 R&D sites worldwide

Takeda aims to deliver medicines matching the various types of patients' needs through its efforts to strengthen the pipeline. One of the ways we can achieve this, is by maximizing our global presence in Europe, the Americas, Asia and Emerging Markets.

¥300 billion R&D expenses per year

Responding to the needs of patients is Takeda's greatest mission. In that spirit, we set our commitment to discovering and developing innovative pharmaceuticals that answer unmet medical needs.We are making strategic investments in a highly-prioritized pipeline of late-stage clinical trials, and working to maximize the efficiency of development costs.

Since 1781

For more than 230 years, Takeda has developed its business with integrity while undergoing a process of continuous transformation.

Takeda began operations in 1781 when Chobei Takeda I started a business selling traditional Japanese and Chinese medicines in Doshomachi, Osaka. Takeda has been supplying pharmaceuticals for over 230 years, during which time we have developed a strong commitment to the highest ethical standards and a strong sense of mission. We have made constant efforts to improve our relationship with society over this time. As we move forward, we will continue to fulfill our responsibilities as a global pharmaceutical company.

Chobei Takeda

1925

1928

1935

1939

Expressing Takeda in Numbers

Based on the corporate philosophy of "Takeda-ism" (Integrity: Fairness, Honesty and Perseverance) developed over its long corporate history of more than 230 years, Takeda conducts activities according to the corporate mission to “strive towards better health for people worldwide through leading innovation in medicine.”